EMPLICITI
elotuzumab
- Strength
- 300 mg/1
- Form
- Injection, Powder, Lyophilized, For Solution
- Class
- SLAMF7-directed Immunostimulatory Antib…
E.R. Squibb & Sons, L.L.C.
Not stocked by us — reference only
elotuzumab
Listed by E.R. Squibb & Sons, L.L.C.
| Dosage form | Injection, Powder, Lyophilized, For Solution |
|---|---|
| Route | Intravenous |
| Drug class | SLAMF7-directed Immunostimulatory Antibody |
| Approval route | BLA — biologic licence |
| NDC code | 0003-4522 |
| FDA application | BLA761035 |
| RxNorm concept | 1726110 |
| Package sizes listed | 1 |
| Marketed since | November 2015 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
elotuzumab
E.R. Squibb & Sons, L.L.C.
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.